Targeted therapy revolutionized cancer treatment, with gene fusions leading the way when the FDA approved imatinib in 2001 to ...

During a Case-Based Roundtable® event, Chul Kim, MD, discussed the ALTA-1 trial and BRIGHTSTAR trials of brigatinib in ALK+ ...

The FDA extended the Prescription Drug User Fee Act date for the biologics license application seeking approval of ...

People living in long-impoverished areas are more likely to have aggressive or advanced breast cancer, undergo the most ...

Nearly 25 years ago, Ann and Jim Pride endured the unimaginable when their son Jeff — a happy boy who liked the color blue ...

The novel drug SHR-A1921 was safe and efficacious in patients with platinum-resistant ovarian cancer, according to phase 1 data.

Ann Wilson, lead singer of the classic rock ... director of precision oncology at Vanderbilt School of Medicine, told ...

Ann Hohenhaus, DVM, DACVIM (Oncology, SAIM), delved into essential components of a diagnostic investigation of dogs with MCRs ...

CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

based Integrated Oncology Network welcomed radiation oncologist ... Detroit-based Barbara Ann Karmanos Cancer Institute welcomed Wasif Saif, MD, as the new leader of the Phase 1 Clinical Trials ...

Tune in to hear more from: Ann Marie Robertson, Chief Commercial Officer, EVP, EVERSANA COMPLETE Oncology, EVERSANA; Barry Vucsko, Senior Vice President, Client Services and Business Development ...

Drs Ann H. Partridge and Jeffrey Peppercorn discuss the growing burden of financial toxicity on cancer survivors.